1 |
Arslan U, Moruzzi A, Nowacka J, Mummery C, Eckardt D, Loskill P, Orlova V. Microphysiological stem cell models of the human heart. Materials Today Bio 2022. [DOI: 10.1016/j.mtbio.2022.100259] [Reference Citation Analysis]
|
2 |
Foglio E, Pellegrini L, Russo MA, Limana F. HMGB1-Mediated Activation of the Inflammatory-Reparative Response Following Myocardial Infarction. Cells 2022;11:216. [PMID: 35053332 DOI: 10.3390/cells11020216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
3 |
Fu Z, Li W, Wei J, Yao K, Wang Y, Yang P, Li G, Yang Y, Zhang L. Construction and Biocompatibility Evaluation of Fibroin/Sericin-Based Scaffolds. ACS Biomater Sci Eng 2022;8:1494-505. [PMID: 35230824 DOI: 10.1021/acsbiomaterials.1c01426] [Reference Citation Analysis]
|
4 |
Garbern JC, Lee RT. Heart regeneration: 20 years of progress and renewed optimism. Dev Cell 2022;57:424-39. [PMID: 35231426 DOI: 10.1016/j.devcel.2022.01.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
|
5 |
Wang J, Yu L, Zhou A, Liu J, Wang K, Luo Y, Wang F. Non-Viral Gene Delivery Systems for Treatment of Myocardial Infarction: Targeting Strategies and Cardiac Cell Modulation. Pharmaceutics 2021;13:1520. [PMID: 34575595 DOI: 10.3390/pharmaceutics13091520] [Reference Citation Analysis]
|
6 |
Arslan U, Orlova VV, Mummery CL. Perspectives for Future Use of Cardiac Microtissues from Human Pluripotent Stem Cells. ACS Biomater Sci Eng 2022. [PMID: 35315663 DOI: 10.1021/acsbiomaterials.1c01296] [Reference Citation Analysis]
|